🇺🇸 FDA
Patent

US 7951820

Triazole compounds useful as protein kinase inhibitors

granted A61PA61P1/16A61P11/06

Quick answer

US patent 7951820 (Triazole compounds useful as protein kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P1/16, A61P11/06, A61P17/06, A61P19/00